Zobrazeno 1 - 10
of 934
pro vyhledávání: ''
Autor:
Andreas Schneeweiss, Wolfgang Wick, Georg Martin Haag, Joachim Wiskemann, Jana Müller, Karen Steindorf, Markus Weiler
Publikováno v:
British Journal of Cancer
Background Chemotherapy-induced peripheral neuropathy (CIPN) is a common, unpleasant and usually long-lasting side effect of neurotoxic chemotherapeutic agents. This study aimed to investigate the preventive potential of sensorimotor- (SMT) and resis
Autor:
Matthew Asare, Kah Poh Loh, Kaitlin Chung, Deborah J. Ossip, Ian R. Kleckner, Luke J. Peppone, Eva Culakova, Todd A. Jusko, Marianne Melnik, Amber S. Kleckner, Karen M. Mustian, Samer Kasbari, Jessica M. Miller, Julia E Inglis
Publikováno v:
Breast Cancer Research and Treatment. 189:521-532
Purpose. Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of taxane and platinum chemotherapy for breast cancer. Clinicians cannot accurately predict CIPN severity partly because its pathophysiology is poorly un
Publikováno v:
Cancer Chemotherapy and Pharmacology. 88:533-542
Genetic variation in the activation of the prodrug cyclophosphamide (CP) by cytochrome P450 (CYP) enzymes has been shown to influence outcomes. However, CYP are also subject to phenoconversion due to either the effects of comedications or cancer asso
Publikováno v:
Br J Cancer
Background We sought to estimate the annual risk and 25-year cumulative risk of contralateral breast cancer among women with stage 0-III unilateral breast cancer. Methods We identified 812,851 women with unilateral breast cancer diagnosed between 199
Autor:
Christoph Kowalski, Friedemann Schad, Lorenz Rieger, Barbara Brückner, Simone Wesselmann, Andreas D. Hartkopf, Jens Uwe Blohmer, Christoph Lindner, Marina Dos Santos Guilherme, Olaf Ortmann, Clara Breidenbach, Nora Tabea Sibert, Elisabeth C. Inwald, Susanne Peschel, Gerhard Gebauer, Julia Ferencz, Sebastian Dieng, Paul Strecker
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:719-726
Since 2008, guidelines recommend that patients with HER2-positive early breast cancer (BC) should receive adjuvant chemotherapy in combination with trastuzumab in Germany. However, recent studies highlight that a substantial share of patients do not
Autor:
Soong June Bae, Dooreh Kim, Junghwan Ji, Su Jung Baik, Sung Gwe Ahn, Joon Jeong, Sung Min Ko, Janghee Lee
Publikováno v:
British Journal of Cancer
Background Our study evaluated the association between body mass index (BMI) and absolute lymphocyte count (ALC) in breast cancer patients and healthy females. Additionally, we determined the prognostic value of these factors in breast cancer. Method
Autor:
Reuben Retnam, Vanessa B. Sheppard, William G Hundley, Dipankar Bandyopadhyay, Arnethea L. Sutton, Ashley S. Felix
Publikováno v:
Breast Cancer Res Treat
PURPOSE: Racial disparities in cardiovascular disease and cardiac dysfunction exist amongst breast cancer survivors. This study examined the prevalence of cardioprotective medication use in survivors and identified factors associated with use by race
Autor:
Yessica C. Martinez, Volker Mai, Maximiliano Tagliamonte, Xuefeng Wang, Maria Ukhanova, Lusine Yaghjyan, Kathleen M. Egan, Shannan N Rich
Publikováno v:
Cancer Causes & Control. 32:681-692
We examined gut microbiome (GM) profiles in relation to mammographic breast density (BD) and body mass index (BMI) in healthy postmenopausal women. Eligible women were postmenopausal, had a BMI ≤ 35 kg/m2, and had not recently taken oral/IV antibio
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 147:3401-3407
The use of complementary and alternative medicine (CAM) is common among breast cancer patients, but less is known about whether CAM influences breast cancer survival. The primary aim of this study was to determine the impact of self-use of herbs on t
Autor:
Tomohiro Miyake, Masafumi Shimoda, Masahiro Yanagawa, Yasuto Naoi, Kenzo Shimazu, Seung Jin Kim, Seiki Hamada, Tomonori Tanei, Yuka Fujita, Noriyuki Tomiyama, Yukiko Tokuda, Keiichiro Honma
Publikováno v:
Breast Cancer Research and Treatment. 188:107-115
To compare the diagnostic performance of ring-type dedicated breast PET (dbPET), whole-body PET (WBPET), and DCE-MRI for predicting pathological complete response (pCR) after neoadjuvant chemotherapy (NAC). This prospective study included 29 women wi